Published in J Clin Endocrinol Metab on April 01, 2004
The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev (2010) 2.90
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid (2015) 2.67
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med (2011) 2.44
New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev (2012) 2.01
Significance of serum procalcitonin in sepsis. Indian J Crit Care Med (2011) 1.76
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care (2006) 1.70
Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol (2009) 1.55
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care (2005) 1.49
Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care (2004) 1.37
Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol (2010) 1.21
Role of biomarkers in sepsis care. Shock (2013) 1.19
Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis (2006) 1.18
Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis (2011) 1.15
Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Int J Chron Obstruct Pulmon Dis (2012) 1.08
Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care (2010) 1.06
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. Nat Clin Pract Endocrinol Metab (2009) 1.03
Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia. J Gen Intern Med (2013) 0.95
Biomarkers in community-acquired pneumonia: a state-of-the-art review. Clinics (Sao Paulo) (2012) 0.94
Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics. J Int AIDS Soc (2013) 0.93
Procalcitonin predicts real-time PCR results in blood samples from patients with suspected sepsis. PLoS One (2012) 0.93
Promising new assays and technologies for the diagnosis and management of infectious diseases. Clin Infect Dis (2012) 0.90
Neonatal levels of acute phase proteins and later risk of non-affective psychosis. Transl Psychiatry (2013) 0.89
Toward an operative diagnosis in sepsis: a latent class approach. BMC Infect Dis (2008) 0.88
Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: implications for septic renal injury. Inflamm Res (2013) 0.84
Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study. BMC Med (2013) 0.82
Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver Failure. PLoS One (2015) 0.82
Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance. Infection (2012) 0.82
Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients. Korean J Intern Med (2015) 0.82
Diagnostic value of procalcitonin for acute complicated appendicitis. Nagoya J Med Sci (2016) 0.81
Validation of new biomarkers in systemic autoimmune diseases. Nat Rev Rheumatol (2011) 0.81
Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study. J Lab Physicians (2013) 0.81
A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis. PLoS One (2014) 0.80
Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia. Headache (2014) 0.80
Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia. PLoS One (2015) 0.79
Procalcitonin kinetics - prognostic and diagnostic significance in septic patients. Arch Med Sci (2016) 0.79
Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia. Cephalalgia (2011) 0.79
Alterations in deoxyribonucleic acid (DNA) methylation patterns of Calca, Timp3, Mmp2, and Igf2r are associated with chronic cystitis in a cyclophosphamide-induced mouse model. Urology (2013) 0.78
Postmortem chemistry update part II. Int J Legal Med (2011) 0.78
Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial. Ital J Pediatr (2009) 0.78
High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population. PLoS One (2015) 0.78
Role of Semi-quantitative Serum Procalcitonin in Assessing Prognosis of Community Acquired Bacterial Pneumonia Compared to PORT PSI, CURB-65 and CRB-65. J Clin Diagn Res (2015) 0.77
Diagnostic value of procalcitonin in pleural effusions. Eur J Clin Microbiol Infect Dis (2010) 0.77
Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin. Inflamm Res (2012) 0.77
Procalcitonin and intestinal ischemia: a review of the literature. World J Gastroenterol (2014) 0.77
Role of Procalcitonin in Evaluation of the Severity of Acute Cholecystitis. Eurasian J Med (2016) 0.77
A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting. Int J Appl Basic Med Res (2013) 0.77
Serum value of procalcitonin as a marker of intestinal damages: type, extension, and prognosis. Surg Endosc (2015) 0.77
Conventional, molecular methods and biomarkers molecules in detection of septicemia. Adv Biomed Res (2015) 0.76
Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. PLoS One (2015) 0.76
Calcium-Sensing Receptor Gene: Regulation of Expression. Front Physiol (2016) 0.76
Diagnostic accuracy of chromogranin A and calcitonin precursors measurements for the discrimination of ectopic ACTH secretion from Cushing's disease. J Clin Endocrinol Metab (2009) 0.76
Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study. BMC Emerg Med (2016) 0.75
Emerging infection and sepsis biomarkers: will they change current therapies? Expert Rev Anti Infect Ther (2016) 0.75
Impact of Low Procalcitonin Results on Antibiotic Administration in Hospitalized Patients at a Tertiary Care Center. Infect Dis Ther (2016) 0.75
Mineral bone disease in maintenance hemodialysis patients: Association with morbidity and mortality. Indian J Nephrol (2014) 0.75
Procalcitonin as diagnostic marker of infection in solid tumors patients with fever. Sci Rep (2016) 0.75
Deletion of the gene encoding calcitonin and calcitonin gene-related peptide α does not affect the outcome of severe infection in mice. Am J Respir Cell Mol Biol (2013) 0.75
The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain (2017) 0.75
Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis. Biotech Histochem (2016) 0.75
Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial. PLoS One (2017) 0.75
Differential effects of Calca-derived peptides in male mice with diet-induced obesity. PLoS One (2017) 0.75
Serial Procalcitonin as a Predictor of Bacteremia and Need for Intensive Care Unit Care in Adults With Pneumonia, Including Those With Highest Severity: A Prospective Cohort Study. Open Forum Infect Dis (2017) 0.75
Soluble thrombomodulin to evaluate the severity and outcome of community-acquired pneumonia. Inflammation (2014) 0.75
Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study. J Gastroenterol (2016) 0.75
Procalcitonin-Guided Antibiotics after Surgery for Peritonitis: A Randomized Controlled Study. Gastroenterol Res Pract (2017) 0.75
Nutrition of Streptococcus bovis. J Bacteriol (1948) 5.77
Transport of vitamin B12 in Escherichia coli: common receptor sites for vitamin B12 and the E colicins on the outer membrane of the cell envelope. J Bacteriol (1973) 4.91
A Study of Streptococci Associated with Subacute Bacterial Endocarditis. J Bacteriol (1946) 4.83
Oxidation of Butyric Acid by Streptococci. J Bacteriol (1945) 4.28
Synthesis of a Polysaccharide from Sucrose by Streptococcus S.B.E. J Bacteriol (1946) 3.29
THE ROLE OF THE BACILLUS WELCHII IN ACUTE INTESTINAL OBSTRUCTION: WITH LIGATION OF THE VEINS TO THE OBSTRUCTED LOOP. Ann Surg (1929) 3.18
LYMPH PRESSURES IN STERILE INFLAMMATION. J Exp Med (1932) 3.05
Noxious conditioning as a treatment for rumination. Ment Retard (1967) 3.05
Characterization of the cell-wall polysaccharides of Arabidopsis thaliana leaves. Plant Physiol (1995) 3.03
ATP-dependent branch migration of Holliday junctions promoted by the RuvA and RuvB proteins of E. coli. Cell (1992) 2.97
Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes (2001) 2.95
A conformational switch controlling HIV-1 morphogenesis. EMBO J (2000) 2.86
Erythropoiesis with Particular Reference to its Study by Biopsy of Human Bone Marrow: A Review. J Clin Pathol (1949) 2.81
Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab (2001) 2.49
Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med (1998) 2.34
Purified U7 snRNPs lack the Sm proteins D1 and D2 but contain Lsm10, a new 14 kDa Sm D1-like protein. EMBO J (2001) 2.29
Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. J Biol Chem (1990) 2.24
Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem (1994) 2.22
The gene for histone RNA hairpin binding protein is located on human chromosome 4 and encodes a novel type of RNA binding protein. EMBO J (1997) 2.19
Transport of vitamin B 12 in Escherichia coli. Location and properties of the initial B 12 -binding site. J Biol Chem (1973) 2.04
Streptococcus S.B.E.: Immunological Characteristics. J Bacteriol (1946) 1.92
Clinical biochemistry. Annu Rev Biochem (1971) 1.92
Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab (1997) 1.88
Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet (1985) 1.88
Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis. Arthritis Rheum (2000) 1.88
The immune response to a hybrid protein molecule; specificity of secondary stimulation and of tolerance induction. J Exp Med (1967) 1.86
NEUROGENIC DISTURBANCES OF THE COLON AND THEIR INVESTIGATION BY THE COLONMETROGRAM: A PRELIMINARY REPORT. Ann Surg (1940) 1.86
Foot and mouth disease: the human consequences. The health consequences are slight, the economic ones huge. BMJ (2001) 1.79
RuvA and RuvB proteins of Escherichia coli exhibit DNA helicase activity in vitro. Proc Natl Acad Sci U S A (1993) 1.77
Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment. Am J Clin Oncol (1999) 1.74
Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer (2000) 1.60
CHANGES IN BRAIN VOLUME AND BLOOD CONTENT AFTER EXPERIMENTAL CONCUSSION. Ann Surg (1943) 1.59
Factors contributing to the inhibition of HIV reverse transcriptase by chain-terminating nucleotides in vitro and in vivo. FEBS Lett (1991) 1.55
Bronchoalveolar lavage. Quantitation of intraalveolar fluid? Am Rev Respir Dis (1993) 1.54
MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Br J Dermatol (2008) 1.53
Graves' ophthalmopathy: natural history and treatment outcomes. Swiss Med Wkly (2001) 1.52
HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group. J Rheumatol (2000) 1.49
Recompression treatments during the recovery of TWA Flight 800. Undersea Hyperb Med (1997) 1.49
Overweight and obesity in children with Attention-Deficit/Hyperactivity Disorder. Int J Obes Relat Metab Disord (2004) 1.48
Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J (2007) 1.47
On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J Med Genet (1994) 1.47
Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry (2009) 1.46
S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells. Leukemia (1991) 1.40
Prospective 10-year follow-up in adolescent anorexia nervosa--course, outcome, psychiatric comorbidity, and psychosocial adaptation. J Child Psychol Psychiatry (2001) 1.38
TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab (2001) 1.37
In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. Virology (1999) 1.37
p53 Protein exhibits 3'-to-5' exonuclease activity. Cell (1996) 1.36
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med (2000) 1.36
Termination of a transcription unit comprising highly expressed genes in the archaebacterium Methanococcus voltae. Nucleic Acids Res (1985) 1.36
Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem (1978) 1.35
Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol (1999) 1.33
Deregulation of EIF4E: a novel mechanism for autism. J Med Genet (2009) 1.31
Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob Agents Chemother (2012) 1.31
Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate. Brain Res (1979) 1.31
BLOOD LOSS IN NEUROSURGICAL OPERATIONS. Ann Surg (1938) 1.29
Vertical distribution of methanogens in the anoxic sediment of Rotsee (Switzerland). Appl Environ Microbiol (1999) 1.28
Thermal resistance of salmonellae and staphylococci in foods. Appl Microbiol (1966) 1.27
Vasculas complications in nephrotic syndrome: relationship to steroid therapy and accelerated thromboplastin generation. Br Med J (1970) 1.26
Gene expression during tuber development in potato plants. FEBS Lett (1990) 1.25
The chloroplast gene ycf9 encodes a photosystem II (PSII) core subunit, PsbZ, that participates in PSII supramolecular architecture. Plant Cell (2001) 1.25
Integrin alphaIIb beta3 reconstituted into lipid bilayers is nonclustered in its activated state but clusters after fibrinogen binding. Biochemistry (1997) 1.25
NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int (1998) 1.25
Reliability and interobserver variability in radiological patellar height ratios. Knee Surg Sports Traumatol Arthrosc (2000) 1.24
RNase H activity of HIV reverse transcriptases is confined exclusively to the dimeric forms. FEBS Lett (1992) 1.24
Functional expression of rat synapse-associated proteins SAP97 and SAP102 in Drosophila dlg-1 mutants: effects on tumor suppression and synaptic bouton structure. Mech Dev (1997) 1.24
Photostability studies of phycobiliprotein fluorescent labels. Anal Biochem (1987) 1.23
Schnurri mediates Dpp-dependent repression of brinker transcription. Nat Cell Biol (2000) 1.22
The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533. Am J Hum Genet (1992) 1.22
Wellbeing of gay, lesbian, and bisexual doctors. BMJ (2001) 1.20
Posterior rhizotomy: a possible substitute for cordotomy in otherwise intractable neuralgias of the trunk and extremities of nonmalignant origin. Clin Neurosurg (1965) 1.20
Quantitative analysis of parenchymal and vascular alterations in NO2-induced lung injury in rats. Eur Respir J (1995) 1.19
Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab (1998) 1.18
Phenotypic features of myoclonus-dystonia in three kindreds. Neurology (2002) 1.17
[Light-induced, reversible increase in the activity of NADP-dependent glyceraldehyde-3-phosphate dehydrogenase in chloroplasts. On the mechanism of the reaction]. Eur J Biochem (1969) 1.16
Direct transcriptional control of the Dpp target omb by the DNA binding protein Brinker. EMBO J (2000) 1.15
Cordotomy: assessment of its effectiveness and suggestions for its improvement. Clin Neurosurg (1965) 1.15
Brinker requires two corepressors for maximal and versatile repression in Dpp signalling. EMBO J (2001) 1.14
Cloning and expression in Escherichia coli and Bacillus subtilis of the hemolysin (cereolysin) determinant from Bacillus cereus. J Bacteriol (1983) 1.13
Leber's hereditary optic neuroretinopathy and the X-chromosomal susceptibility factor: no linkage to DXs7. Hum Hered (1992) 1.13
Cloning and characterization of the poly(hydroxyalkanoic acid)-depolymerase gene locus, phaZ1, of Pseudomonas lemoignei and its gene product. Eur J Biochem (1993) 1.13
Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy. J Med Genet (1990) 1.12
Deterministic and probabilistic approaches for tracking virus particles in time-lapse fluorescence microscopy image sequences. Med Image Anal (2009) 1.12
Familial periodic nystagmus, vertigo, and ataxia. Arch Neurol (1969) 1.11
Neurotensin induces hyperplasia of the pancreas and growth of the gastric antrum in rats. Gut (1987) 1.11
Hot spot of recombination within DXS164 in the Duchenne muscular dystrophy gene. Am J Hum Genet (1989) 1.11
Radioimmunoassay of calcitonin in human plasma. Clin Chem (1974) 1.11
Comparative analysis of genes encoding methyl coenzyme M reductase in methanogenic bacteria. Mol Gen Genet (1988) 1.10
Ectopic secretion of calcitonin by oat-cell carcinoma. N Engl J Med (1974) 1.09
Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat. Prostaglandins (1986) 1.08
A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia. J Endocrinol Invest (2001) 1.08
Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol (1997) 1.08
On the mechanism of the light-induced activation of the NADP-dependent glyceraldehyde phosphate dehydrogenase. Biochim Biophys Acta (1970) 1.08
Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. J Clin Invest (1986) 1.07
CD14, new aspects of ligand and signal diversity. Microbes Infect (2000) 1.07
Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem Pharmacol (1991) 1.07